| 陈 猛,夏昌发,刘 冰.中国子宫颈低级别鳞状上皮内病变患者经济负担分析[J].中国肿瘤,2021,30(11):827-833. |
| 中国子宫颈低级别鳞状上皮内病变患者经济负担分析 |
| Economic Burden of Cervical Low-grade Squamous Intraepithelial Lesion in China |
| 中文关键词 修订日期：2021-05-03 |
| DOI：10.11735/j.issn.1004-0242.2021.11.A005 |
|
 |
| 中文关键词: 子宫颈低级别鳞状上皮内病变 诊疗 随访复查 经济负担 |
| 英文关键词:low-grade squamous intraepithelial lesions of cervix diagnosis and treatment follow-up review economic burden |
| 基金项目:比尔及梅琳达·盖茨基金会（OPP1216421） |
|
| 摘要点击次数: 1095 |
| 全文下载次数: 147 |
| 中文摘要: |
| 摘 要：［目的］ 探讨子宫颈低级别鳞状上皮内病变（LSIL）患者诊疗全过程的经济负担。［方法］ 采用横断面调查方法，对450例LSIL患者诊疗费用信息进行分析，分别估算患者寻求确诊阶段、临床治疗阶段和随访随诊阶段的直接经济负担与间接经济负担，并以此估算全国LSIL患者诊疗总体经济负担情况。［结果］ 患者平均年龄为（43.4±9.6）岁，患者诊疗全过程的例均费用为11 066.4元，包括直接经济负担10 430.5元、间接经济负担635.9元。患者在寻求确诊、临床治疗和随访随诊阶段的例均费用分别为1 610.0元、3 828.9元和5 627.5元。估算全国每年LSIL患者的诊治费用约为48 692.2万元，如全部采用规范化管理方式，预计全国每年可节省直接医疗费用、直接非医疗费用和间接经济负担分别为28 672.8万元、2 930.8万元和2 202.2万元。［结论］ 当前我国LSIL患者的经济负担较重，规范化的患者管理模式可大幅降低患者支出和卫生经费负担。 |
| 英文摘要: |
| Abstract：［Purpose］ To explore the economic burden of the diagnosis and treatment for patients with cervical low-grade squamous intraepithelial lesion（LSIL）. ［Methods］ By using the method of cross-sectional survey， the costs of diagnosis and treatment of 450 patients with cervical LSIL were analyzed. The economic burden of patients for the diagnosis， treatment and follow-up was calculated respectively. Based on previous calculation， the overall economic burden of diagnosis and treatment for LSIL patients in China was estimated. ［Results］ The average age of the patients was（43.4±9.6) years. The average overall cost of diagnosis and treatment was 11 066.4 Yuan， including direct economic burden of 10 430.5 Yuan and indirect economic burden of 635.9 Yuan. The average cost of patients for diagnosis， treatment and follow-up was 1 610.0， 3 828.9 and 5 627.5 Yuan， respectively. It is estimated that the annual cost of diagnosis and treatment for LSIL patients is about 486.922 million Yuan in China. If all the standardized management methods were adopted， the national direct medical expenses， direct non-medical expenses and indirect economic burden would be saved by 286.728 million Yuan， 29.308 million Yuan and 22.022 million Yuan， respectively. ［Conclusion］ The economic burden for LSIL patients is relatively high in China. The standardized management would significantly reduce the patients’ economic burden and health expenditure. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |